Trump Admin Vows to Crack Down on Drug Ads

Trump’s Crackdown on Prescription Drug Ads: What to Know

President Donald Trump has directed the Food and Drug Administration (FDA) to ramp up its efforts to ensure that advertising of prescription drugs directed to consumers is transparent and accurate. That includes requiring drug makers to provide more information on the risks of using the drug, and stepping up enforcement of federal laws regulating these ads. This action, ordered by a presidential memorandum on Sept. 9, could have far-reaching imp…

Trump Admin Vows to Crack Down on Drug Ads

(MedPage Today) -- Pharmaceutical companies will be required to include full safety warnings in direct-to-consumer ads, HHS and FDA announced Tuesday. The policy change would reverse one from 1997 that opened the door to now-ubiquitous TV drug...

White House Asks FDA To Review Pharma Advertising On TV

President Trump on Tuesday issued a memorandum directing the FDA and HHS to crack down on misleading direct-to-consumer prescription drug ads, requiring clearer disclosure of risks and ensuring that promotions don't overstate benefits or push costly drugs over generics. Longtime Slashdot reader sini...

Trump directs HHS, FDA to require full safety warnings in drug ads

President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies to include full safety warnings on their consumer advertisements. HHS and the FDA announced they will remove a loophole from a 1997 provision that allowed drug advertisers to display safety information in a different format or location. Additionally, HHS said the FDA would begin aggressive …

President Trump signs a memorandum seeking to reinstate a pre-1997 policy that would sharply restrict prescription drug advertising on TV and social media

Mediagazer presents the day's must-read media news on a single page.